“Health is essential to people's fundamental
happiness and a foundation of
prosperous countries.”

Dr. Naoko Yamamoto

Assistant Minister for Global Health
Minister's Secretariat
Ministry of Health, Labour and Welfare

STAKEHOLDER INTERVIEWS

“Japan really was a
logical choice,
but was difficult to approach
as an outsider.
That all changed with
GHIT’s establishment.”

Dr. David Reddy

Medicines for Malaria Venture (MMV) CEO

STAKEHOLDER INTERVIEWS

“Japan has a vibrant pharmaceutical industry,
which will continue to push on research.”

Mr. Christophe Weber

Representative Director, President and CEO
Takeda Pharmaceutical Company Limited

STAKEHOLDER INTERVIEWS

“We can support the ecosystem
for their creation by gathering those
who can tangibly foster innovatiovn
and advance product development..
That all changed
with GHIT's establishment.”

SPONSOR INTERVIEWS

NEWSJourney with us through GHIT’s Past and Future

GHIT FUND HISTORYOur first 5 years (2013-2017)

GHIT FUND FUTUREPlans for the next 5 years (2018-2022)

Coming June 2017

STAKEHOLDER INTERVIEWSPerspectives from 15 global health leaders on
GHIT's catalytic role and Japan's transformational
contributions to global health R&D

FUNDING

Dr. Naoko YamamotoAssistant Minister for Global Health
Minister's Secretariat
Ministry of Health, Labour and Welfare

Available in May 2017

Dr. Hannah KettlerSenior Program Officer, Life Science Partnerships
Global Health Program, Office of the President
Bill & Melinda Gates Foundation

Available in August 2017

Prof. Stephen CaddickWellcome Trust

DISCOVERY

Dr. David ReddyCEO
Medicine for Malaria Venture (MMV)

Available in May 2017

Mr. George NakayamaRepresentative Director, Chairman and CEO
Daiichi Sankyo Company, Limited

Available in June 2017

Prof. Kiyoshi KitaProfessor Emeritus, The University of Tokyo
Professor and Dean, Nagasaki University School of Tropical Medicine and Global Health

DEVELOPMENT

Mr. Christophe WeberRepresentative Director, President and CEO
Takeda Pharmaceutical Company Limited

Available in May 2017

Mr. Yoshihiko HatanakaRepresentative Director, President and CEO
Astellas Pharma Inc.

Available in July 2017

Dr. Nathalie Strub WourgaftMedical Officer
Drugs for Neglected Diseases initiative (DNDi)

ACCESS

Available in June 2017

Dr. Jayasree K. IyerExecutive Director
Access to Medicine Foundation

Available in July 2017

Mr. Tetsuo KondoDirector
UNDP Representation Office in Tokyo

Available in August 2017

To be announced

POLICY

Available in June 2017

Dr. Mark DybulExecutive Director
Global Fund

Available in July 2017

Dr. Seth BerkleyCEO
Gavi

Available in August 2017

Hon. Prof. Keizo TakemiMember of the House of Councillors of Japan
Chairman, Special Committee onGlobal Health Strategy
of the Liberal Democratic Party's Policy

SPONSOR INTERVIEWSOur shared vision drives creative partnerships for global health innovation

All Nippon Airways
Yahoo! JAPAN

Available in May 2017

salesforce.com Co.,Ltd.

Available in June 2017

MORRISON FOERSTER

Available in July 2017

Mori Building Co., Ltd.

Available in August 2017

STAFF STORYDiverse paths lead to global health R&D

Coming Fall 2017